The ASX 200 dropped sharply on Monday after oil prices jumped in response to escalating conflict in the Middle East.
Market pullbacks like this can be unsettling in the short term, but we often look back on them and realise they were incredible buying opportunities.
With that in mind, here are 10 ASX 200 shares that could be worth considering after the recent selloff.
Cochlear Ltd (ASX: COH)
Cochlear is a global leader in implantable hearing solutions. Its products help people with severe hearing loss regain the ability to hear. With an ageing global population and strong demand for hearing solutions, Cochlear has a long runway for growth.
CSL Ltd (ASX: CSL)
CSL is one of Australia’s most successful healthcare companies. Its plasma therapies division and vaccines business provide life-saving treatments to patients around the world. Demand for the biotech’s therapies is expected to grow steadily as global healthcare needs expand. And while its recent performance has been disappointing, it could be worth being patient with this ASX 200 share.
Goodman Group (ASX: GMG)
Goodman Group develops and manages logistics facilities and data infrastructure across major global cities. Its warehouses support ecommerce supply chains while its data centre developments benefit from the rapid growth of cloud computing and artificial intelligence (AI).
Light & Wonder Inc. (ASX: LNW)
Another ASX 200 share to look at is Light & Wonder. It is a global gaming technology company operating across casino gaming, digital gaming, and social gaming. Its portfolio of games and platforms provides exposure to the growing global gaming and entertainment industry.
Pro Medicus Ltd (ASX: PME)
Pro Medicus could be worth a shout after recent weakness. It develops medical imaging software used by hospitals and healthcare providers around the world. Its Visage platform is widely regarded as one of the most advanced radiology imaging systems available, supporting strong contract wins and long-term growth.
REA Group Ltd (ASX: REA)
REA Group operates realestate.com.au, Australia’s leading online property marketplace. Its dominant position gives it strong pricing power and recurring revenue from real estate listings and related services.
ResMed Inc. (ASX: RMD)
ResMed specialises in devices and software for treating sleep apnoea and other respiratory conditions. Millions of people remain undiagnosed globally, providing significant long-term demand for this ASX 200 share’s sleep therapy products.
TechnologyOne Ltd (ASX: TNE)
TechnologyOne is a leading enterprise software provider focused on government, education, and large organisations. Its transition to a cloud-based software model has improved recurring revenue and strengthened customer retention.
WiseTech Global Ltd (ASX: WTC)
WiseTech develops logistics software used by freight forwarders and global supply chains. Its CargoWise platform helps businesses manage complex international trade processes, positioning the company to benefit from long-term growth in global logistics.
Xero Ltd (ASX: XRO)
A final ASX 200 share that could be a buy is Xero. It provides cloud-based accounting software for small and medium-sized businesses. With millions of subscribers across multiple markets, the company continues to expand its ecosystem of financial tools and services. And with an estimated total addressable market of 100 million businesses, it has a very long growth runway.
The post 10 ASX 200 shares to buy after the market selloff appeared first on The Motley Fool Australia.
Should you invest $1,000 in Cochlear Limited right now?
Before you buy Cochlear Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Cochlear Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- 3 ASX shares down 30% (or more) to buy right now
- 3 ASX 200 shares at 52-week lows I’d buy before they recover
- 5 things to watch on the ASX 200 on Tuesday
- 1 ASX growth share down 36% to buy right now
- Why the CSL share price just hit a 9-year low
Motley Fool contributor James Mickleboro has positions in CSL, Cochlear, Goodman Group, Pro Medicus, REA Group, ResMed, Technology One, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, Goodman Group, Light & Wonder Inc, ResMed, Technology One, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended ResMed, WiseTech Global, and Xero. The Motley Fool Australia has recommended CSL, Cochlear, Goodman Group, Light & Wonder Inc, Pro Medicus, and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.